Minnesota Health Center COVID-19 Survey Summary Report

Latest data from October 8, 2021

Number of Health Center respondents = 11 (69% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 1,431
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) 47.80%
Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 158
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) 41.38%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, antigen)2 Patients Tested Positive, Virus Detection (PCR, antigen)2
White, Non-Hispanic/Latino Patients 46.47% 53.80%
White, Hispanic/Latino Patients 9.22% 4.43%
Black/African American, Non-Hispanic/Latino Patients 11.39% 9.49%
Black/African American, Hispanic/Latino Patients 0.07% 0.00%
Asian Patients3 2.87% 3.80%
American Indian/Alaska Native Patients3 16.35% 15.82%
Native Hawaiian/Other Pacific Islander Patients3 0.28% 0.63%
Patients with More than one race3 0.91% 0.63%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 1.47% 3.16%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 1.68% 0.00%
Unreported/Refused to Report Race and Ethnicity 9.29% 8.23%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 464
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 85.45%
COVID-19 Immunization Series Completed 464
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 86.71%
COVID-19 Immunization Series Additional 464
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 13.56%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 13.36% 12.72% 81.03%
White, Hispanic/Latino Patients 22.63% 28.88% 3.02%
Black/African American, Non-Hispanic/Latino Patients 31.03% 20.91% 2.80%
Black/African American, Hispanic/Latino Patients 0.00% 0.22% 0.22%
Asian Patients3 8.19% 7.97% 3.23%
American Indian/Alaska Native Patients3 3.23% 7.11% 2.37%
Native Hawaiian/Other Pacific Islander Patients3 0.00% 0.00% 0.22%
Patients with More than one race3 0.86% 0.86% 0.22%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 12.50% 17.03% 0.65%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 1.08% 1.29% 0.65%
Unreported/Refused to Report Race and Ethnicity 7.11% 3.02% 5.60%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)

Metrics Value
Less Than 1 Hour 9.09%
1 to 24 Hours 36.36%
More Than 24 Hours 54.55%
N/A 0.00%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 0.00%
Staffing to administer the vaccine 27.27%
Vaccine confidence 36.36%
Vaccine storage capacity 9.09%
Vaccine supply 9.09%
Other 0.00%
None 54.55%

Operations and Staff

Metrics Value
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program 0.00%
Average Percent of Health Center Visits Conducted Virtually 23.64%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 54.55%
Number of Mobile Van Sites 2
Number of Pop-up Clinics 8
Number of School-Based Vaccination Sites 2

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 0.00%
Refer patients to another organization that provides monoclonal antibody therapies 63.64%
None 36.36%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 0.00%
Patient awareness/education 0.00%
Staffing capacity 18.18%
Therapy administration/onsite logistics 18.18%
Other 9.09%
None 63.64%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

Date Last Reviewed:  October 2021